Betta Pharmaceuticals Co., Ltd. (300558.SZ)
300558.SZ Stock Price Chart
Explore Betta Pharmaceuticals Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300558.SZ price movements and trends.
300558.SZ Company Profile
Discover essential business fundamentals and corporate details for Betta Pharmaceuticals Co., Ltd. (300558.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
9 Nov 2016
Employees
1.96K
Website
https://www.bettapharma.comCEO
Lieming Ding
Description
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China.
300558.SZ Financial Timeline
Browse a chronological timeline of Betta Pharmaceuticals Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 17 Jun 2025
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 17 Jun 2025.
Earnings released on 24 Apr 2025
EPS came in at ¥0.24 falling short of the estimated ¥0.45 by -46.67%, while revenue for the quarter reached ¥917.55M, beating expectations by +13.39%.
Earnings released on 17 Apr 2025
EPS came in at -¥0.03 falling short of the estimated ¥0.38 by -107.89%, while revenue for the quarter reached ¥547.31M, missing expectations by -27.61%.
Earnings released on 28 Oct 2024
EPS came in at ¥0.46 surpassing the estimated ¥0.22 by +109.09%, while revenue for the quarter reached ¥843.88M, beating expectations by +11.25%.
Earnings released on 5 Aug 2024
EPS came in at ¥0.54 surpassing the estimated ¥0.19 by +184.21%, while revenue for the quarter reached ¥760.24M, missing expectations by -1.32%.
Dividend declared on 6 Jun 2024
A dividend of ¥0.17 per share was announced, adjusted to ¥0.17. The dividend was paid on 6 Jun 2024.
Earnings released on 15 May 2024
EPS came in at ¥0.23 surpassing the estimated ¥0.23 by +1.96%, while revenue for the quarter reached ¥730.66M.
Earnings released on 19 Apr 2024
EPS came in at ¥0.10 falling short of the estimated ¥0.32 by -68.75%, while revenue for the quarter reached ¥412.39M, missing expectations by -37.38%.
Earnings released on 24 Oct 2023
EPS came in at ¥0.37 surpassing the estimated ¥0.09 by +311.11%, while revenue for the quarter reached ¥729.67M, beating expectations by 0.00%.
Earnings released on 25 Aug 2023
EPS came in at ¥0.23 surpassing the estimated ¥0.07 by +228.57%, while revenue for the quarter reached ¥782.26M, beating expectations by +11.73%.
Dividend declared on 15 Jun 2023
A dividend of ¥0.07 per share was announced, adjusted to ¥0.07. The dividend was paid on 15 Jun 2023.
Earnings released on 27 Apr 2023
EPS came in at ¥0.12 surpassing the estimated ¥0.12 by +2.58%, while revenue for the quarter reached ¥531.62M, missing expectations by 0.00%.
Earnings released on 23 Apr 2023
EPS came in at ¥0.10 matching the estimated ¥0.10, while revenue for the quarter reached ¥713.91M, beating expectations by +21.28%.
Earnings released on 28 Oct 2022
EPS came in at ¥0.02 falling short of the estimated ¥0.16 by -87.50%, while revenue for the quarter reached ¥409.38M, missing expectations by -41.45%.
Earnings released on 25 Aug 2022
EPS came in at ¥0.03 falling short of the estimated ¥0.20 by -85.00%, while revenue for the quarter reached ¥668.63M, missing expectations by -18.30%.
Dividend declared on 30 May 2022
A dividend of ¥0.25 per share was announced, adjusted to ¥0.25. The dividend was paid on 30 May 2022.
Earnings released on 26 Apr 2022
EPS came in at ¥0.20 falling short of the estimated ¥0.21 by -4.76%, while revenue for the quarter reached ¥584.71M, missing expectations by -5.09%.
Earnings released on 31 Dec 2021
EPS came in at ¥0.09 falling short of the estimated ¥0.18 by -51.92%, while revenue for the quarter reached ¥521.44M, missing expectations by -3.83%.
Earnings released on 27 Oct 2021
EPS came in at ¥0.31 falling short of the estimated ¥0.48 by -35.42%, while revenue for the quarter reached ¥569.27M.
Earnings released on 10 Aug 2021
EPS came in at ¥0.16 falling short of the estimated ¥0.31 by -48.39%, while revenue for the quarter reached ¥536.59M.
Earnings released on 29 Apr 2021
EPS came in at ¥0.35 surpassing the estimated ¥0.24 by +45.83%, while revenue for the quarter reached ¥618.56M.
Dividend declared on 26 Apr 2021
A dividend of ¥0.31 per share was announced, adjusted to ¥0.31. The dividend was paid on 26 Apr 2021.
Earnings released on 26 Mar 2021
EPS came in at ¥0.23 falling short of the estimated ¥0.27 by -14.81%, while revenue for the quarter reached ¥362.54M.
Earnings released on 28 Oct 2020
EPS came in at ¥0.91 surpassing the estimated ¥0.25 by +264.00%, while revenue for the quarter reached ¥555.84M.
Earnings released on 6 Aug 2020
EPS came in at ¥0.03 falling short of the estimated ¥0.14 by -78.57%, while revenue for the quarter reached ¥304.81M.
300558.SZ Stock Performance
Access detailed 300558.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.